Circulating acetylated polyamines correlate with Covid-19 severity in cancer patients

Cancer patients are particularly susceptible to the development of severe Covid-19, prompting us to investigate the serum metabolome of 204 cancer patients enrolled in the ONCOVID trial. We previously described that the immunosuppressive tryptophan/kynurenine metabolite anthranilic acid correlates with poor prognosis in non-cancer patients. In cancer patients, we observed an elevation of anthranilic acid at baseline (without Covid-19 diagnosis) and no further increase with mild or severe Covid-19. We found that, in cancer patients, Covid-19 severity was associated with the depletion of two bacterial metabolites, indole-3-proprionate and 3-phenylproprionate, that both positively correlated with the levels of several inflammatory cytokines. Most importantly, we observed that the levels of acetylated polyamines (in particular N1-acetylspermidine, N1,N8-diacetylspermidine and N1,N12-diacetylspermine), alone or in aggregate, were elevated in severe Covid-19 cancer patients requiring hospitalization as compared to uninfected cancer patients or cancer patients with mild Covid-19. N1-acetylspermidine and N1,N8-diacetylspermidine were also increased in patients exhibiting prolonged viral shedding (>40 days). An abundant literature indicates that such acetylated polyamines increase in the serum from patients with cancer, cardiovascular disease or neurodegeneration, associated with poor prognosis. Our present work supports the contention that acetylated polyamines are associated with severe Covid-19, both in the general population and in patients with malignant disease. Severe Covid-19 is characterized by a specific metabolomic signature suggestive of the overactivation of spermine/spermidine N1-acetyl transferase-1 (SAT1), which catalyzes the first step of polyamine catabolism.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:13

Enthalten in:

Aging - 13(2021), 17 vom: 13. Sept., Seite 20860-20885

Sprache:

Englisch

Beteiligte Personen:

Bourgin, Mélanie [VerfasserIn]
Derosa, Lisa [VerfasserIn]
Silva, Carolina Alves Costa [VerfasserIn]
Goubet, Anne-Gaëlle [VerfasserIn]
Dubuisson, Agathe [VerfasserIn]
Danlos, François-Xavier [VerfasserIn]
Grajeda-Iglesias, Claudia [VerfasserIn]
Cerbone, Luigi [VerfasserIn]
Geraud, Arthur [VerfasserIn]
Laparra, Ariane [VerfasserIn]
Aprahamian, Fanny [VerfasserIn]
Nirmalathasan, Nitharsshini [VerfasserIn]
Madeo, Frank [VerfasserIn]
Zitvogel, Laurence [VerfasserIn]
Kroemer, Guido [VerfasserIn]
Durand, Sylvère [VerfasserIn]

Links:

Volltext

Themen:

0YS975XI6W
Anthranilic acid
COVID-19
Cancer
Cytokines
Inflammation Mediators
Journal Article
Metabolomics
Microbiota
Ortho-Aminobenzoates
Polyamines
Propionates
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 01.10.2021

Date Revised 03.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.18632/aging.203525

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM330594931